Capio Nomination Committee proposal of Board members to the Annual General Meeting 2016

The Nomination Committee of Capio AB (publ.) intends to propose the following
composition of Board members to the AGM, May 11, 2016.
Reelection of:
Anders Narvinger, Chairman of the Board of Directors, Gunnar Nemeth, Vice
Chairman of the Board of Directors, Gun Nilsson and Fredrik Näslund.

New Board members:
Birgitta Stymne Göransson, Pascale Richetta, Michael Flemming and Arnaud
Bosquet.

Neal Dignum and Håkan Winberg have declined reelection.

Summary of biographies, new Board members:

Birgitta Stymne Göransson (b. 1958)
Birgitta Stymne Göransson is currently working as Senior Industrial Advisor and
as non-executive Board member in a series of Nordic companies, among others
Elekta, Sophiahemmet, Medivir (Chairman) and BioInvent. Prior to her full time
Board engagements in 2013, Birgitta served as Group CEO of Memira 2010-2013 and
CEO of Semantix 2006-2010. During her career, Birgitta has held several
executive management positions in Swedish companies such as Telefos, Åhléns , KF
and Gambro as well as having worked five years at McKinsey&Company.

Birgitta Stymne Göransson holds an MSc in Chemical Engineering and Biotechnology
from KTH Royal Institute of Technology in Stockholm and an MBA from Harvard
Business School in the US.

Pascale Richetta (b.1959)
Pascale Richetta is currently Executive Vice President at the biopharma company
UCB in Belgium. Pascale joined UCB in February 2016 from the pharmaceutical
company AbbVie where she was Vice President Western Europe and Canada (2013
-2016). Prior to those positions, Pascale held several executive management
positions in Abbott Laboratories (2004-2013) in France and Belgium, Glaxo Smith
Kline (1994-2004) in France and the UK, Beaufour-Ipsen and Servier in France.

Pascale Richetta is a Doctor of Medicine from the University of Poitiers in
France (1986).

Michael Flemming (b. 1957)
Michael Flemming is executive business advisor and Board member of Medicover
Holdings. Michael has an extensive career within the healthcare industry joining
the South African company Afrox Healthcare in 1994. After various executive
management positions in the company, Michael was appointed Managing Director of
Afrox Healthcare Limited in 2001. In 2005, the company was delisted and became
Life Healthcare Group Limited and after five years in private custody, the
company made an IPO in 2010. After further expansion, Michael retired from Life
Healthcare in September 2014.

Michael Flemming holds a Bachelor of Commerce degree from the University of the
Witwatersrand and a Bachelor of law and BProc degrees from the University of
South Africa (UNISA) as well as an AMP from Harvard Business School in the US.

Arnaud Bosquet (b.1983)
Arnaud Bosquet is a Vice President at Apax Partners LLP, based in London. Arnaud
already served as a board member to Capio from 2012 to 2013. Prior to joining
Apax Partners LLP in 2011, Arnaud worked in Deutsche Bank's Investment Banking
division.

Arnaud Bosquet holds an MBA with Distinction from INSEAD and an MSc in General
Engineering from École Centrale de Lille, France.

Capio Nomination Committee
Robert Furuhjelm, Nordic Capital, Chairman of the Committee
Steven Dyson, Apax Partners LLP
Per Hesselmark, R12 Kapital
Per Colleen, Fourth National Swedish Pension Fund
Bo Lundgren, Swedbank Robur Funds
Anders Narvinger, Chairman of the Board of Directors Capio AB (publ.)

Nomination Committee in Capio AB (publ.)

Capio AB (publ) is required to publish the above information under the Swedish
Financial Instruments Trading Act. The information was submitted for publication
on February 11, 2016 at 13.45 CET.
Capio AB (publ) is a leading, pan-European healthcare provider offering a broad
range of high quality medical, surgical and psychiatric healthcare services in
four countries through its hospitals, specialist clinics and primary care units.
In 2014, Capio’s 12,357 employees provided healthcare services during 4.6
million patient visits across the Group’s facilities in Sweden, Norway, France
and Germany, generating net sales of MSEK 13,200. Capio operates across three
geographic segments: Nordic (54 percent of Group net sales 2014), France (37
percent of Group net sales 2014) and Germany (9 percent of Group net sales
2014). For more information about Capio, please see www.capio.com.